VY PLUS EUROPEAN LEADERS
Join us on:
The Pandemic was a big test for technology and Artificial Intelligence. We relied on science, tech and AI to face the crisis. Yet we remain dubious of an all-embracing digital world.
In what ways are technological innovations shaping healthcare and ensuring a better future?
Ivy Plus European Leaders
in partnership wih HEC International and Alumni Alliance
is delighted to invite you to a cutting-edge forum on the mesmerizing advances in heathcare, putting the limelight on award-winning actors of the tech-medical field, inspiring entrepreneurs and researchers developing new treatments and new generation of cures, precision diagnoses and personalized medicine.
Tech, Artificial Intelligence, and the Future of Health
Dr. Laurent ALEXANDRE
Renowned French Surgeon-urologist, Neurobiologist, Entrepreneur,
Founder of Doctissimo and DNAVision, Investor and Author
Co-Founder and CEO Bit Bio
Founder and CEO Nanobiotix (tbc)
Head Pathology Dpt Hôpital Lariboisière
Head Digital Research Society Domain Orange
Tuesday 30 November 2021 – 6:30 p.m.
Cercle de l’Union Interalliée
Keynote: Dr. Laurent
Surgeon-Urologist, Neurobiologist, Founder of Doctissimo & DNAVision, Author
Laurent Alexandre holds a medical degree from Pierre and Marie Curie University (Paris VI). He is also a graduate of IEP (Institut des Etudes Politiques - Sciences Po), HEC, and ENA. A renowned entrepreneur and author, founder of the Doctissimo website and DNAVision, providing state of the art DNA analysis. Dr. Alexandre has written numerous books and essays on the progress of science in the field of biotechnology, medicine and genetics, AI, transhumanism, and upheavals awaiting humanity.
Co-Founder and CEO Bit Bio
Applying Principles of Computation to Biology
Florian Schuster is the co-founder and CEO of Bit Bio, a human synthetic biology company. Bit Bio has developed a breakthrough technology which combines synthetic and stem cell biology, with precise reprogramming of cells –
“coding cells for health”. Previously,
he was CFO & Head of Strategic Partnerships for Tessa Therapeutics, a clinical-stage cell therapy company. Florian is a former investment banker, a graduate of the
Stanford School of
Engineering, and Harvard
Founder and CEO ARIANA Pharma
AI for precision medicine
Mohammad Afshar is the President and CEO of Ariana Pharma, a leading digital health company founded in 2003 as a spin-off of Institut Pasteur. Ariana has developed the AI Platform KEM, an advanced, clinical and biomarker data analytics technology to analyze complex data sets and provide personalized medicine. He holds an MD, a MPhil in Computer Science, a PhD in structural biochemistry and a “Habilitation doctorate” from the Faculty of Medicine of the University of Montpellier, France.
Founder and CEO NANOBIOTIX
a global biotech company
Pioneer of Nanomedicine, researcher and entrepreneur, Laurent Levy was one of the first entrepreneurs to work on the development of nanomedicines and new radiotherapy techniques for cancer treatments. Dr. Levy holds a Doctorate in Physical Chemistry from Pierre and Marie Curie University (Paris VI) and CEA (Commissariat à l’Énergie Atomique et aux Énergies Alternatives). He founded the award-winning company Nanobiotix in 2003, introduced on the Nasdaq in 2020.
Tech and vaccines (RNA
Pr. Homa Adle-Biassette
Professor Adle-Biassette is Head of the Department of Pathology Hôpital Lariboisière - Paris & its Platform of Bio-Pathology and Innovative Pathology in Health. She holds MD & PhD degrees and specialization degrees from Denis-Diderot Univ (Paris VII), Pierre and Marie-Curie University (Paris VI).
Chair: Maria Adle, President Ivy Plus European Leaders
Co-Moderator: Tram Trinh, VP Ivy Plus European Leaders, Founder Vitanlink
The talks will be in French and English - followed by Q&A
Among his works : Jouissez Jeunesse(Lattès), La Guerre des Intelligences(Lattès), La Mort de la Mort, La Défaite du Cancer…
a Cocktail Reception in the beautiful salons of the Cercle de l’Union Interalliée.